HAEMONETICS CORP — Director's Dealing 2015

Jan 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2015-01-22

Reporting Person: Burns Brian R (EVP, Global QA/RA)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-01-22	Common Stock	D	237.0	$37.14	Disposed	6103	Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.